A multicenter random assignment phase II study of irinotecan and flavopiridol versus irinotecan alone for patients with p53 wild-type gastric adenocarcinoma (NCI 8060) Meeting Abstract
| Authors: | Shah, M. A.; Smyth, E. C.; Shibata, S.; Yong, W.; Tang, L. H.; Janjigian, Y. Y.; Kelsen, D. P.; Schwartz, G. K. |
| Abstract Title: | A multicenter random assignment phase II study of irinotecan and flavopiridol versus irinotecan alone for patients with p53 wild-type gastric adenocarcinoma (NCI 8060) |
| Meeting Title: | 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 28 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2010 Jun 4-8 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2010-05-20 |
| Start Page: | 33s |
| Language: | English |
| ACCESSION: | WOS:000208852002209 |
| DOI: | 10.1200/jco.2010.28.15_suppl.tps209 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS209 -- S -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work